Personalized Medicine Coalition Applauds New Health Care Reform Law
Washington, D.C. (March 24, 2010)– The Personalized Medicine Coalition (PMC) praised the landmark health care reform legislation signed into law this week, noting that it represents the first time the principles of personalized medicine were formally voted on and passed by both houses of Congress and signed into law by a president. Also significant is the bill’s alignment of personalized medicine with the conduct and use of comparative effectiveness research (CER).
"PMC has been working over the past year in support of policy solutions that listen to the science and advance the interest of patients by incorporating personalized medicine into comparative effectiveness research,” said Amy Miller, policy director of the Personalized Medicine Coalition. “This new legislation is a major step forward as it ensures that future comparative effectiveness research will be personalized to benefit patients."
The new health care reform bill enacted into law (H.R. 3590) incorporates the tenets of personalized medicine throughout the structure of its CER provisions. Therefore, health care reform will:
- Include primary research on molecularly-informed trials in the research agenda;
- Ensure research recognizes potential differences, including genetic and molecular sub-typing;
- Improve the quality of the science generated by CER, incorporating new information and technological innovations into its studies, reviewing and updating evidence as necessary, and outlining what future research will be necessary to address perceived gaps;
- Incorporate research on patient preferences in the scope of work, including patient quality of life and physician choice; and
- Create an independent research methods committee that includes experts in molecular diagnostics.
"With the passage of this watershed bill, policymakers can now turn their attention to the issues surrounding medical innovation, improved patient care, and reduced systemic costs,” said Edward Abrahams, president of the Personalized Medicine Coalition. “Personalized medicine and targeted therapeutics will help us get there.”
Liza Morris Acting Communications Director
About the Personalized Medicine Coalition
The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. For more information on the Personalized Medicine Coalition, please visit www.PersonalizedMedicineCoalition.org.